At Novo Nordisk, we recognize some patients face financial challenges when undergoing guideline-recommended non-invasive testing for liver disease. The NovoDETECT® Liver Disease Testing Support Program is designed to assist your patients in managing these costs effectively.
If your patients are denied coverage or incur copays through their private or commercial insurance (such as employer-sponsored insurance) for testing, they can enroll into the NovoDETECT®Liver Disease Testing Support Program to access support for testing costs. NovoDETECT® complies with all relevant privacy guidelines, including HIPPA.
- Patients pay as little as $25 per liver disease test.
- Financial support of up to $3,000 per calendar year.
- Coverage for three CPT® codes associated with liver testing, including vibration-controlled transient elastography (VCTE) and relevant blood tests.
To qualify for support through the NovoDETECT® program, patients must meet the following criteria:
- Insurance: Patient must have commercial insurance. Patients enrolled in any federal or state healthcare program such as Medicare, Medicaid, Veterans Affairs (VA), Department of Defense (DoD), or TRICARE are not eligible.
- Residency: Patient must be a resident of the United States, Puerto Rico, or U.S. Territories.
- 76981 (Liver elastography, mechanically induced shear wave).
- 91200 (Ultrasound elastography; parenchyma (e.g., organ), with imaging).
- 81517 (Liver fibrosis analysis, with interpretation and report, using a multi-analyte lab test).
Direct patients to the NovoDETECT® Liver Disease Testing Support portal to enroll into the program; submit their EOB and copy of their receipt.
- Submit via the portal or by mail.
If the claim is eligible, NovoDETECT® will issue a check to the patient for the difference between their payment and the $25 that remains their responsibility, with a maximum support limit of $3,000 per calendar year.
If you have any questions, please call 1-833-747-4004